Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503

Weiwei Wang, Yan Hao, Feng Li

DOI: 10.1080/21691401.2019.1671434
Published: 2019-10-04
Container: Artificial Cells, Nanomedicine, and Biotechnology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2019.1671434,
  title = {Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503},
  author = {Weiwei Wang and Yan Hao and Feng Li},
  year = {2019},
  journal = {Artificial Cells, Nanomedicine, and Biotechnology},
  doi = {10.1080/21691401.2019.1671434},
  url = {https://doi.org/10.1080/21691401.2019.1671434}
}

RIS

TY  - JOUR
TI  - Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503
AU  - Weiwei Wang
AU  - Yan Hao
AU  - Feng Li
PY  - 2019
JO  - Artificial Cells, Nanomedicine, and Biotechnology
DO  - 10.1080/21691401.2019.1671434
UR  - https://doi.org/10.1080/21691401.2019.1671434
ER  -

APA

Wang, W., Hao, Y., & Li, F. (2019). Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503. Artificial Cells, Nanomedicine, and Biotechnology. https://doi.org/10.1080/21691401.2019.1671434

Source records

crossref · retrieved 2026-09-25T22:02:37.918Z